GB16362-2010
The requirements for quality assurance and radiological protection for patients in teletherapy
远距治疗患者放射防护与质量保证要求
GB 16362-2010 is a current mandatory Chinese national standard for The requirements for quality assurance and radiological protection for patients in teletherapy. It appears in the Food compliance cluster with a product safety focus and has an implementation date of May 1, 2011.
Applicability depends on product scope, certification route, competent authority notices and transition rules. Requst for the translation or verify source before using this record in a compliance decision.
Compliance overview
Scope and applicability
This standard applies to the practices of teletherapy using medical electron accelerators, medical gamma-ray devices, and X/gamma-ray stereotactic radiosurgery (commonly known as X-knife and gamma-knife). It explicitly excludes practices using deep X-ray therapy machines. It is mandatory for all medical institutions and manufacturers involved in external beam radiation therapy in China.
Technical requirements
The standard specifies fundamental principles for patient radiological protection and quality assurance (QA) in teletherapy. It mandates that radiation therapy units establish a dedicated radiological protection and quality control management organization. Facilities must implement strict justification protocols, ensuring treatment is only prescribed when benefits outweigh risks. Treatment plans must be jointly signed by qualified radiation oncologists and medical physicists, with special precautions required for pregnant women and children. For patient protection, the standard requires detailed treatment planning including target dose distribution and fractionation. It mandates the calculation of absorbed doses to critical organs outside the target volume, utilizing organ shielding and appropriate techniques to keep normal tissue exposure as low as reasonably achievable (ALARA). Furthermore, interlock systems and anti-pinch protection measures for shielding doors must be fully operational. Regarding quality assurance, the standard outlines requirements for the validation and use of treatment planning systems (TPS), which must be licensed by national medical device authorities. It also dictates that clinical treatment data must be collected by qualified medical physicists and periodically reviewed. Radiotherapy devices must undergo rigorous acceptance, status, and stability testing to ensure continuous operational safety.
Testing methods
The standard outlines three primary categories of quality control testing for radiotherapy equipment: acceptance testing (after new installation or major repairs), status testing (conducted annually by qualified institutions), and stability testing (routine checks compared against baseline values). Testing procedures must align with referenced standards such as GB/T 17856 and GB/T 19046. Additionally, facilities are encouraged to participate in domestic or international TLD (Thermoluminescent Dosimeter) dose comparison programs to verify dosimetric accuracy.
FAQs
What equipment and practices are regulated under GB 16362-2010?
The standard applies to medical electron accelerators, medical gamma ray devices used in external beam therapy, and X-ray/gamma-ray stereotactic radiosurgery (X-knife, gamma knife). It does not apply to deep X-ray therapy machines.
Are there any significant updates from the previous version, GB 16362-1996?
The updated version shifts terminology to "radiation therapy units," integrates requirements from the *Regulations for Radiological Diagnosis and Treatment Management*, and adds specific quality control requirements for radiotherapy simulators and treatment planning systems.
How does GB 16362-2010 relate to international standards?
It aligns with fundamental international radiation safety principles but specifically mandates Chinese national standards (such as GBZ 179 and GB 18871) for operational protocols, personnel qualifications, and domestic quality assurance testing procedures.
The summary above provides a high-level overview of GB 16362-2010. To ensure complete compliance for your medical devices and treatment protocols entering the Chinese market, a precise and professional translation of the full technical specifications is essential. Purchase our high-quality English translation of GB 16362-2010 today to access all detailed parameters, acceptance testing formats, and quality control procedures.
Applicability hints
- Type
- Health and hygiene
- CCS
- C57
- ICS
- 13.280
- Competent department
- National Health Commission
- Technical committee
- National Health Commission
Relationships
Replaces:GB 16362-1996